Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in REPL — Replimune Group, Inc.

CIK 923093 STAMFORD, CT

Position in REPL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$1,247,853 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
12 quarters on record

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Derivatives in REPL

reported options exposure · as of Mar 31, 2026
CallValue
$4,834,035
CallShares
631,900
PutValue
$382,500
PutShares
50,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TUDOR INVESTMENT CORP ET AL holds $333,275,952 across 117 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in REPL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $382,500 50,000
2026-03-31 $4,834,035 631,900
2025-12-31 $368,388 37,900
2025-12-31 $486,000 50,000
2025-12-31 $1,247,853 128,380
2025-09-30 $87,005 20,765
2024-09-30 $227,047 20,716
2024-06-30 $264,357 29,373
2024-03-31 $99,845 12,221
2023-06-30 $669,595 28,837
2023-03-31 $435,619 24,667
2022-12-31 $867,571 31,896
2022-09-30 $422,251 24,450
2022-06-30 $408,035 23,343
2022-03-31 $430,154 25,333